Purus Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Sell
2,885
-367
-11% -$30.7K 0.07% 144
2026
Q1
$260K Sell
3,252
-60
-2% -$4.95K 0.08% 128
2025
Q4
$282K Hold
3,312
0.09% 114
2025
Q3
$258K Sell
3,312
-190
-5% -$14.8K 0.08% 121
2025
Q2
$274K Sell
3,502
-147
-4% -$11K 0.1% 109
2025
Q1
$264K Buy
3,649
+60
+2% +$4.29K 0.11% 102
2024
Q4
$266K Buy
3,589
+354
+11% +$24.8K 0.11% 99
2024
Q3
$213K Buy
3,235
+23
+0.7% +$1.67K 0.09% 114
2024
Q2
$297K Buy
3,212
+160
+5% +$14.2K 0.13% 91
2024
Q1
$292K Sell
3,052
-151
-5% -$12.7K 0.14% 88
2023
Q4
$244K Buy
3,203
+72
+2% +$5.01K 0.14% 110
2023
Q3
$217K Buy
3,131
+68
+2% +$5.46K 0.15% 111
2023
Q2
$289K Buy
3,063
+35
+1% +$3.04K 0.19% 90
2023
Q1
$250K Buy
3,028
+40
+1% +$3.14K 0.2% 99
2022
Q4
$223K Buy
2,988
+20
+0.7% +$1.54K 0.2% 99
2022
Q3
$245K Sell
2,968
-11
-0.4% -$1.06K 0.23% 89
2022
Q2
$283K Buy
2,979
+70
+2% +$7.25K 0.25% 82
2022
Q1
$342K Buy
2,909
+1,229
+73% +$138K 0.24% 81
2021
Q4
$218K Buy
+1,680
New +$196K 0.14% 105

Other funds holding EW

Purus Wealth Management's EW Position: Q2 2026 in Review

Purus Wealth Management reduced its Edwards Lifesciences (EW) stake by 11% in Q2 2026, selling an estimated $30.7K and leaving 2,885 shares worth $261K. The position accounts for 0.07% of the portfolio, ranked #144.

Purus Wealth Management first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $342K in Q1 2022. 195 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Purus Wealth Management held 2,885 shares of Edwards Lifesciences worth $261K as of Q2 2026.
  • Purus Wealth Management sold 367 Edwards Lifesciences shares in Q2 2026, an estimated $30.7K.
  • Edwards Lifesciences made up 0.07% of Purus Wealth Management's portfolio in Q2 2026, its #144 holding.
  • Purus Wealth Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • Purus Wealth Management's Edwards Lifesciences position peaked at $342K in Q1 2022.
  • 195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Purus Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.